Health Care & Life Sciences » Pharmaceuticals | Kindred Biosciences Inc.

Kindred Biosciences Inc.

Kindred Biosciences Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
33.8 M
Public Float
20.47 M
Kindred Biosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.66
Market Cap
$321.4 M
Shares Outstanding
39.01 M
Public Float
36.38 M

Profile

Address
1555 Bayshore Highway
Burlingame California 94010
United States
Employees -
Website http://www.kindredbio.com
Updated 07/08/2019
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.

Financials

View All

Richard H. Chin
President, Chief Executive Officer & Director
Joseph S. McCracken
Director